BlackRock’s Nuvectis Pharma NVCT Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$5.91M Sell
764,441
-18,364
-2% -$157K ﹤0.01% 3758
2025
Q4
$5.91M Buy
782,805
+97,468
+14% +$635K ﹤0.01% 3764
2025
Q3
$4.13M Buy
685,337
+42,355
+7% +$291K ﹤0.01% 3851
2025
Q2
$4.8M Buy
642,982
+574,498
+839% +$5.21M ﹤0.01% 3792
2025
Q1
$669K Buy
68,484
+6,142
+10% +$44.2K ﹤0.01% 4314
2024
Q4
$337K Buy
62,342
+12,788
+26% +$80.1K ﹤0.01% 4517
2024
Q3
$312K Sell
49,554
-33,858
-41% -$223K ﹤0.01% 4430
2024
Q2
$528K Sell
83,412
-289,309
-78% -$1.97M ﹤0.01% 4332
2024
Q1
$3.06M Sell
372,721
-15,170
-4% -$129K ﹤0.01% 3856
2023
Q4
$3.24M Buy
387,891
+28,444
+8% +$254K ﹤0.01% 3862
2023
Q3
$4.63M Buy
359,447
+44,956
+14% +$651K ﹤0.01% 3686
2023
Q2
$5.02M Buy
314,491
+300,935
+2,220% +$4.8M ﹤0.01% 3728
2023
Q1
$178K Buy
13,556
+3,395
+33% +$34.4K ﹤0.01% 4811
2022
Q4
$76.2K Sell
10,161
-3,842
-27% -$27.5K ﹤0.01% 5122
2022
Q3
$100K Buy
14,003
+6,805
+95% +$63.4K ﹤0.01% 5173
2022
Q2
$80K Sell
7,198
-674
-9% -$8.33K ﹤0.01% 5297
2022
Q1
$59K Buy
+7,872
New +$54.8K ﹤0.01% 5389

Other funds holding NVCT